Skip to main content
AKBA logo

AKBA · Akebia Therapeutics, Inc. · Executive Compensation

Track AKBA — free
$0.42 +0.01 (+3.28%) At close · Nov 19 Play latest call Q3 2026 earnings call transcript
Market Cap
$117.26M
Shares
277.66M
Volume · Nov 19 2.75M Avg daily vol (3M) 8.17M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John P. Butler $5,652,339
Steven Burke $1,859,815
Erik Ostrowski $1,792,361
Nicholas Grund $1,728,405
Fiscal 2024
Executive Total
John P. Butler $4,260,114
Nicholas Grund $1,854,631
Steven Burke $1,811,027
Erik Ostrowski $1,215,122
Michel Dahan $1,212,463
Ellen Snow $1,048,621
Fiscal 2023
Executive Total
John P. Butler $2,775,123
Ellen Snow $1,715,814
Michel Dahan $1,245,374
Steven Burke $1,213,048
Nicole R. Hadas $1,046,304
David A. Spellman $942,627
Fiscal 2022
Executive Total
John P. Butler $3,072,538
David A. Spellman $1,585,841
Steven Burke $1,378,557
Michel Dahan $1,287,386
Nicole R. Hadas $1,240,038
Fiscal 2021
Executive Total
John P. Butler $3,133,316
David A. Spellman $1,721,477
Steven Burke $1,346,572
Michel Dahan $1,267,970
Nicole R. Hadas $1,230,453

Executive changes

Person Change Filed
Nicholas Grund Resigned 2026-10-14
Philip J. Vickers, Ph.D. Appointed 2026-04-01
Myles Wolf Already on the board
Since at least 2020: re-election or new board role
2025-06-13
John P. Butler Appointed 2025-06-13
Erik Ostrowski Appointed 2024-06-24
Ellen Snow Resigned 2024-03-15
Richard C. Malabre Appointed 2024-01-08
Nicole R. Hadas Terminated 2023-08-01
Michel Dahan Terminated 2023-08-01
Ellen Snow Appointed 2023-06-13
David A. Spellman Resigned 2023-06-13
LeAnne M. Zumwalt Already on the board
Since at least 2021: re-election or new board role
2023-06-08
Michael Rogers Already on the board
Since at least 2018: re-election or new board role
2023-06-08
Adrian Adams Already on the board
Since at least 2018: re-election or new board role
2023-06-08
Violetta Cotreau Resigned 2022-12-15
Ron Frieson Appointed 2021-11-01

Leadership

Key facts CIK 1517022 CUSIP 00972D105 13F (30d) 157 filings 140 filers Visit website Investor relations